MedTrace Logo

Effect of Coenzyme Q10 on Diabetic Children

NCT06361680 · Status: NOT_YET_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-04-12

No results posted yet for this study

Summary

Determine the effect of Coenzyme Q10 on random blood sugar and glycosylated haemoglobin

Conditions

  • Type 1 Diabetes Mellitus

Interventions

DRUG

Coenzyme Q10 Cap/Tab as natural factors capsules or kirkman tablets

Group A will take Soft gel capsules or tablets of Coenzyme Q10 in a dose of 100-200mg of natural factors or kirkman but group B will not take Coenzyme Q10 just observe them

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Christina Saad Abdel Malak Abdel Nour · Study producer

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-30
Primary Completion
2025-10-30
Completion
2025-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06361680 on ClinicalTrials.gov